OncoSec Medical Inc (ONCSQ)

[nramos]

ONCS Next two days

People like to say "Sell on the news" which I have seen sometimes. BUT in Oncosec case this news is very substantial and not yet considered in our PPS. If Long term P1 has a good OS then will only give MERCK more substantial evidence to invest in us. If P2 final data is safe and effective like it has been it will only give better rational for our P2b study that will most likely get FAST track by the FDA.

Yes I did use "if" a couple times in this post but based on past we will see a big appreciation following data and what FUTURE benefits we will get from them. That's what PPS is determined on future estimates and if the data is good will only benefit our future even more with merck and our trial with PD-1.

This is a strong buy for rest of 2014 and 2015. IMO